Kimia Biosciences Ltd
Kimia Biosciences Ltd Live Price Chart
Performance
| Previous Close | ₹ 28.5 |
| High | ₹ 29.15 |
| Volume | 1532 |
| 52W Range | ₹ 23.2 - ₹ 43.28 |
| Open | ₹ 29.15 |
| Low | ₹ 28 |
| Market Cap | ₹ 150.93 Cr |
Kimia Biosciences Ltd Technicals
| 20 Day | ₹ 28.801 |
| 50 Day | ₹ 30.398 |
| 100 Day | ₹ 31.724 |
| 200 Day | ₹ 33.596 |
| 20 Day | ₹ 28.688 |
| 50 Day | ₹ 30.792 |
| 100 Day | ₹ 32.985 |
| 200 Day | ₹ 32.104 |
Kimia Biosciences Ltd Fundamentals
| ROCE | 22.809 |
| P/E Ratio | 18.420 |
| P/B Ratio | 7.480 |
| Industry P/E | 7.480 |
| Debt to Equity | 51.431 |
| ROE | 41.950 |
| EPS | 1.520 |
| Dividend Yield | 0.000 |
| Book Value | 3.746 |
| Face Value | 1.000 |
Kimia Biosciences Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 120.2411 | 106.5183 | 129.7291 | 125.8331 | 135.17 |
| Total Expenses | 106.6069 | 113.702 | 141.0692 | 130.8513 | 129.6356 |
| Profit After Tax | 9.6124 | -5.3087 | -9.3522 | -3.703 | 5.1044 |
Kimia Biosciences Ltd Shareholding Pattern
| Promoter Holdings | 74.939 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.383 % |
| Retail | 22.879 % |
| Others - | 1.799 % |
About Kimia Biosciences Ltd
Kimia Biosciences Limited, formerly known Laurel Organics Limited was incorporated in September, 1993. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The name of the Company was changed from 'Laurel Organics Limited' to 'Kimia Biosciences Limited' w.e..f 4 January, 2019. Since then, it engages in the business of Pharmaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.'95 to part-finance the project. Commercial production commenced in May '95. During the 1998-99, the company has become a sick industrial units. The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking. .The Hon'ble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006, directing them to file an application before the Ho'ble BIFR only to redress grievances. Therefore, M/s Ranbaxy Lab. Ltd had filed an application-dated 31.10.06 before the Hon'ble BIFR, requesting them to consider issuance of appropriate corrective orders. The Board has re-confirmed its earlier order. Therefore, despite negative net worth, the Company is out of BIFR purview. Pursuant to Sc ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 43.53 -0.38 (-0.87%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 515.05 -1.35 (-0.26%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 7,081.00 -40.1 (-0.56%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 587.05 +27.95 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,740.00 +361.6 (+1.37%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,418.00 -1.9 (-0.13%) |
FAQs on Kimia Biosciences Ltd
1. Can I buy Kimia Biosciences Ltd from PL Capital? ›
2. Does Kimia Biosciences Ltd pay dividends? ›
3. What is the current share price of Kimia Biosciences Ltd ? ›
4. What is the 52-week high and low of Kimia Biosciences Ltd ? ›
Start SIP in Kimia Biosciences Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
